Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

Microneedles could be a better and easier way to regrow hair.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Classifying hair diseases, like alopecia, is difficult and needs more research to understand their causes.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Early treatment helps stop hair loss in women of color.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Early detection and histopathology are crucial to prevent permanent hair loss in cicatricial alopecia.

Current treatments for cicatricial alopecia can manage symptoms but don't stop hair loss or the disease.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.